No Data
Express News | Twist Bioscience Corp - Pure Biologics' Exploratory Phase 0 Study to Evaluate Pharmacodynamic Activity of PBA-0405 in Solid Tumors
Express News | Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries
Express News | Twist Bioscience Corp : Leerink Partners Raises Target Price to $55 From $36
Buy Rating Justified by Strong Demand and Strategic Expansion of Twist Bioscience's Express Genes
Take the Zacks Approach to Beat the Markets: NVIDIA, Twist Bioscience, Ollie's Bargain Outlet in Focus
These Are the Stocks With the Highest Increase in Short Interest Within Life Sciences and Diagnostics - Baird